BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Lung
,
Human chorionic gonadotropin
,
Bleomycin
,
rs6983267
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ACS
Summary
General Info
Curated Studies
Most Correlated Studies
Melanoma expression following melphalan ILI plus ADH-1 treatment
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Muscle regeneration in Emerin and Lamin AC KO mice
Bone marrow stromal cells treated with sotatercept (ACE-011)
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with anal…
Adenylyl cyclases in the digestive system.
Store-operated Ca²⁺-entry and adenylyl cyclase.
Adenylyl cyclase 3/adenylyl cyclase-associated protein 1 (CAP1) complex mediates the anti-migratory …
Chemical activation of adenylyl cyclase Rv1625c inhibits growth of Mycobacterium tuberculosis on cho…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of ACE Genotype on Cardiovascular Rehabilitation
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
The POST-ACS Study
The ACE Follow-up Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ